Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Patch vs. pill: new ozanimod skin patch tested in healthy volunteers

NCT ID NCT06528665

First seen Feb 27, 2026 · Last updated Jun 11, 2026 · Updated 20 times

Summary

This study tested a new way to deliver the drug ozanimod using a skin patch instead of oral capsules. 24 healthy adults either took one capsule or wore a patch for 7 days. Researchers measured drug levels in the blood and checked for skin reactions to see if the patch works well and is safe.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hospital Ampang

    Ampang, Selangor, 68000, Malaysia

Conditions

The condition(s) this trial relates to.

multiple sclerosis ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.